海洋沉积物来源链霉菌属次生代谢产物及其生物活性研究进展

海洋沉积物是营养较为丰富的微生物栖息地,近年来从海洋沉积物中分离培养出了大量海洋链霉菌,从中还发现了一些新的属种。人们已从海洋沉积物来源链霉菌属中发现了许多具有药用价值的活性化合物,有力推动了海洋天然产物化学的发展,并为新药研发提供基础。本文就海洋沉积物来源链霉菌属次生代谢产物的结构类型及其生物活性进行简要综述。     

海绵来源真菌天然产物的研究进展

随着海洋药物及其药物先导化合物研究的不断深入,海绵来源微生物,因其种类繁多、代谢产物复杂多样,引发了科研工作者的兴趣。许多化合结构新颖、具有强烈生物活性的化合物从海绵来源真菌中发现,包括多肽、生物碱、聚酮类、萜类等。本文仅就近几年来所报道的海绵来源真菌新天然产物的结构类型及其生物活性做简要介绍。     

昆虫共生菌的次级代谢产物研究进展

微生物与昆虫的共生是一种普遍现象,昆虫种类繁多,与昆虫共生的微生物也多种多样。昆虫共生菌是活性次生代谢产物的重要来源。本文对自2008年以来已报道的177个昆虫共生菌的次级代谢产物进行了统计和分析,结果表明:61.6%的化合物为新天然产物(生物碱类新化合物最多),其中,约75%的新化合物来源于昆虫共生真菌,25%来源于细菌;醌酮类化合物是昆虫共生菌源天然产物的主要结构类型,占23.2%;47.5%的化合物具有显著的抗肿瘤、抗菌、除草和抗氧化等生物活性,且化合物中的主要活性类型是抗菌和抗肿瘤活性,活性范围覆盖面最广的结构类型是生物碱类。以上结果表明昆虫共生菌的次级代谢产物是先导性化合物的重要来源且具有丰富的生物活性类型。本文以天然产物的结构分类为切入点,结合其研究菌株来源、生物活性等进行综述,旨在为充分挖掘昆虫共生菌次级代谢产物提供重要参考。     

Nigrospora 属真菌化学成分及生物活性研究进展CSCD

Nigrospora属真菌是常见的药用动植物内生真菌,其次级代谢产物结构多样且生物活性显著,是药用活性物质的重要来源。本文对1997年至2021年报道的Nigrospora属真菌化学成分及其生物活性首次进行了系统综述,涵盖聚酮、蒽醌、萜、甾体和生物碱等199个化合物,并总结其抗菌、抗氧化、抗病毒、抗糖尿病和抗肿瘤等生物活性,以期为该属真菌药用成分的深度开发提供参考。     

链霉菌次级代谢调控相关的双组分系统研究进展

链霉菌具有强大的次级代谢能力, 能够产生众多具有生物活性的次级代谢产物, 如目前广泛应用的抗生素、抗肿瘤药物以及免疫抑制剂等。在链霉菌中, 次级代谢产物的生物合成受到包括途径特异性、多效性以及全局性调控基因在内的多层次严格调控。关键调控基因的缺失或过表达可以显著影响次级代谢产物的生物合成, 提示对于链霉菌次级代谢重要调控基因的功能及其作用机制的研究具有巨大的潜在应用价值。其中, 作为细菌信号传导系统的双组分系统(Two-component system, TCS)一直是大家研究的关注点。越来越多的研究表明TCS在链霉菌次级代谢过程中发挥着全局性的调控功能。本文重点介绍链霉菌模式菌株——天蓝色链霉菌中TCS(包括典型TCS)、孤立的组氨酸蛋白激酶(HK)以及应答调控蛋白(RR)参与次级代谢调控的研究进展。这些TCS的功能鉴定及机制解析为工业链霉菌的定向遗传改造以提高重要次级代谢产物的含量提供了理论依据。     

不同生境来源杂色曲霉次级代谢产物研究进展

杂色曲霉是曲霉属的常见种类，广泛分布于海洋、高等植物、红树林和节肢动物等生境中，近年研究表明杂色曲霉可产生生物碱、萜类、聚酮等结构多样的次级代谢产物，具有抗菌、抗肿瘤、抗氧化、抗病毒等活性。本文总结了2017—2022年间报道的37株杂色曲霉次级代谢产物结构及其生物活性的研究进展，涉及325个次级代谢产物，其中新化合物111个。本文揭示了杂色曲霉的次级代谢产物与生境的相关性，对从更多生境来源的杂色曲霉及其它微生物资源来挖掘新天然产物具有参考作用。     

海洋来源放线菌中新生物碱成分研究进展

因其独特的生活环境,海洋来源的放线菌具有新颖的代谢途径。近年来从海洋来源的放线菌分离出大量的生物碱,具有独特的化学结构与多种生物活性,有些已进入临床前研究。这些活性生物碱为药物研发提供了丰富的先导化合物。本文介绍了2010年以来国内外报道的海洋来源放线菌中新生物碱的化学结构、来源与生物活性,旨在对海洋来源放线菌生物碱的研究奠定基础。     

链霉菌底盘细胞的开发现状及其应用

天然产物及其衍生物在现代医疗中扮演着举足轻重的角色,其生物活性多样性以及化学结构的丰富性是新药研发的源泉和动力。利用纯化学方法合成天然产物在技术和成本上有很大的困难,加上许多天然产物的原始产生菌具有培养条件苛刻、产量低下等缺点,而且大量基因簇在原始菌株中是沉默的,这使得利用合成生物学思想来指导天然产物生物合成基因簇的异源表达具有重大意义。作为抗生素、抗肿瘤活性物质、免疫抑制剂等次级代谢产物主要来源的放线菌一直是研究者们关注的焦点,特别是随着基因测序技术的飞速发展,人们发现链霉菌基因组中包含着极为丰富的天然产物生物合成基因簇资源。这意味着开发链霉菌底盘细胞作为异源表达宿主有其得天独厚的优势。本综述从底盘细胞开发的意义入手,重点阐述链霉菌底盘细胞构建的策略及现状,随后通过实例阐述了各种底盘链霉菌的实际应用。     

放线菌与枯草芽孢杆菌的共培养及其对活性次生代谢产物的影响

为探讨共培养对放线菌产生活性次生代谢产物的影响,结合抗菌活性测定及HPLC-PDA分析,研究了22株放线菌的单培养及其与枯草芽孢杆菌的共培养发酵代谢产物的差异,并选取抗菌活性较强的链霉菌FXJ2.014进一步研究其代谢产物。发现FXJ2.014、FXJ1.296、AS4.1252三株菌与枯草芽孢杆菌共培养时产生其在相同条件下单培养时没有的物质,其中链霉菌FXJ2.014单培养时主要产生醌霉素A,共培养时产物中增加了醌霉素结构类似物FXJ2.014-HB。进一步的抗菌、抗肿瘤活性测定结果表明,两者的生物活性有较显著的差异,且FXJ2.014-HB对多种肿瘤细胞系的抑制活性普遍弱于高毒性的醌霉素A,为有潜力的细胞毒性较小的抗生素。共培养是一条很有希望的发掘放线菌活性次生代谢产物的新途径。     

海绵来源链霉菌S52-B中氨酰胺天然产物的分离与鉴定

【背景】海洋微生物是复杂海洋生态环境中重要的生物资源之一。海洋微生物所产生的活性天然产物极为丰富,是药物或药物先导化合物的重要来源。【目的】探索海洋中海绵来源链霉菌Streptomycessp.S52-B的优势生长条件,挖掘其次级代谢产物,以期分离具有良好生物活性的天然产物。【方法】根据"One Strain Many Compounds"(OSMAC)策略,寻找利于Streptomyces sp. S52-B生长和次级代谢产物产生的优势培养基,结合质谱及特征性的紫外吸收谱图,选择培养基进行大量发酵。利用正相硅胶柱色谱、葡聚糖凝胶柱色谱和制备型高效液相色谱等进行分离纯化,并应用高分辨质谱和核磁共振光谱进行化合物结构解析。【结果】确定培养基A–D为海洋链霉菌S52-B的优势培养基,基于紫外吸收光谱与质谱分析,从培养基A的大量发酵物中分离鉴定3个具有吡咯并[4,3,2-de]喹啉核心结构的含氯化合物,属于氨酰胺类天然产物,其中Ammosalic acid为新结构化合物。【结论】已知含有吡咯并喹啉母核的氨酰胺类家族化合物具有优良的抗癌活性。本研究从海绵来源链霉菌S52-B中分离鉴定了3个氨酰胺类化合物,其中一个是新结构化合物,不仅丰富了此类化合物家族的结构类型,也为研究其生物合成途径中的未知机理奠定了基础,还有利于结合培养条件和基因组信息从这株海绵来源链霉菌中挖掘新结构的活性天然产物。     

Glucose-stimulated acidogenesis by Streptomyces peucetius

Cultures of Streptomyces peucetius often were observed to divert spontaneously from the production of anthracycline antibiotics to the excretion of acidic metabolites, whether grown in a defined medium or a nutrient-rich medium. The predominant excreted acidic metabolites were determined by high-performance liquid chromatography to be pyruvate and 2-oxoglutarate. The acidification occurred at high frequencies when glucose was the primary carbon source in a defined medium, at intermediate frequencies when fructose was the primary carbon source, and did not occur when either maltose, starch, or dextrin were used as primary carbon sources.     

一株海洋链霉菌MMHS020的抗菌活性代谢产物

【背景】海洋微生物因其生存环境的多样性与独特性,已成为天然产物研究的重要来源。【目的】以一株太平洋海泥来源链霉菌MMHS020为出发菌株,筛选可促进其产生丰富代谢产物的发酵条件,挖掘菌株在抗菌抗肿瘤方面的潜力。【方法】采用单菌株多次级代谢产物策略对MMHS020菌株进行培养诱导,使其产生更丰富的活性代谢产物。双层平板法测定发酵产物对6种指示菌的抑菌活性。以硅胶柱层析、葡聚糖凝胶层析和制备层析等方法对代谢产物进行分离纯化,再通过质谱技术和~1H-NMR和~(13)C-NMR对化合物进行结构解析。【结果】链霉菌属MMHS020菌株可在较高浓度盐离子环境中产生丰富的抑菌活性代谢产物,显示出对枯草芽孢杆菌、结核分枝杆菌和藤黄微球菌等多种指示菌的抑制活性。从发酵产物中分离鉴定了3个化合物,分别是诺卡胺素(1)、麦角甾醇(2)和星形孢菌素(3)。其中星形孢菌素表现出白色念珠菌的抑制活性,而诺卡胺素则对其他几个指示菌表现出较强的抑制活性。【结论】海洋链霉菌MMHS020菌株可代谢产生丰富多样的生物活性物质,具有开发成为新型抑菌生物制剂的潜力。     

Chemical analyses of wasp-associated streptomyces bacteria reveal a prolific potential for natural products discovery

Identifying new sources for small molecule discovery is necessary to help mitigate the continuous emergence of antibiotic-resistance in pathogenic microbes. Recent studies indicate that one potentially rich source of novel natural products is Actinobacterial symbionts associated with social and solitary Hymenoptera. Here we test this possibility by examining two species of solitary mud dauber wasps, Sceliphron caementarium and Chalybion californicum. We performed enrichment isolations from 33 wasps and obtained more than 200 isolates of Streptomyces Actinobacteria. Chemical analyses of 15 of these isolates identified 11 distinct and structurally diverse secondary metabolites, including a novel polyunsaturated and polyoxygenated macrocyclic lactam, which we name sceliphrolactam. By pairing the 15 Streptomyces strains against a collection of fungi and bacteria, we document their antifungal and antibacterial activity. The prevalence and anti-microbial properties of Actinobacteria associated with these two solitary wasp species suggest the potential role of these Streptomyces as antibiotic-producing symbionts, potentially helping defend their wasp hosts from pathogenic microbes. Finding phylogenetically diverse and chemically prolific Actinobacteria from solitary wasps suggests that insect-associated Actinobacteria can provide a valuable source of novel natural products of pharmaceutical interest.     

Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species

Natural products produced by microorganisms are important starting compounds for drug discovery. Secondary metabolites, including antibiotics, have been isolated from different Streptomyces species. The production of these metabolites depends on the culture conditions. Therefore, the development of a new culture method can facilitate the discovery of new natural products. Here, we show that mycolic acid-containing bacteria can influence the biosynthesis of cryptic natural products in Streptomyces species. The production of red pigment by Streptomyces lividans TK23 was induced by coculture with Tsukamurella pulmonis TP-B0596, which is a mycolic acid-containing bacterium. Only living cells induced this pigment production, which was not mediated by any substances. T. pulmonis could induce natural-product synthesis in other Streptomyces strains too: it altered natural-product biosynthesis in 88.4% of the Streptomyces strains isolated from soil. The other mycolic acid-containing bacteria, Rhodococcus erythropolis and Corynebacterium glutamicum, altered biosynthesis in 87.5 and 90.2% of the Streptomyces strains, respectively. The coculture broth of T. pulmonis and Streptomyces endus S-522 contained a novel antibiotic, which we named alchivemycin A. We concluded that the mycolic acid localized in the outer cell layer of the inducer bacterium influences secondary metabolism in Streptomyces, and this activity is a result of the direct interaction between the mycolic acid-containing bacteria and Streptomyces. We used these results to develop a new coculture method, called the combined-culture method, which facilitates the screening of natural products.     

Impact of the first <Emphasis Type="Italic">Streptomyces</Emphasis> genome sequence on the discovery and production of bioactive substances

An important addition to the field of bacterial genomics is the recent publication of the complete genome sequence of Streptomyces coelicolor. This strain has been for some decades the model organism for streptomycetes and other filamentous actinomycetes, Gram-positive bacteria highly valuable for their ability to produce thousands of bioactive metabolites, many of which have found important applications in medicine and agriculture. We discuss here the impacts that the S. coelicolor genome sequence is likely to have on the production of bioactive metabolites by current industrial strains, on the possible development of future superhost(s) for the production of valuable drugs, and on the search for new bioactive substances from microbial sources.     

Streptomyces as symbionts: an emerging and widespread theme?

Streptomyces bacteria are ubiquitous in soil, conferring the characteristic earthy smell, and they have an important ecological role in the turnover of organic material. More recently, a new picture has begun to emerge in which streptomycetes are not in all cases simply free-living soil bacteria but have also evolved to live in symbiosis with plants, fungi and animals. Furthermore, much of the chemical diversity of secondary metabolites produced by Streptomyces species has most likely evolved as a direct result of their interactions with other organisms. Here we review what is currently known about the role of streptomycetes as symbionts with fungi, plants and animals. These interactions can be parasitic, as is the case for scab-causing streptomycetes, which infect plants, and the Streptomyces species Streptomyces somaliensis and Streptomyces sudanensis that infect humans. However, in most cases they are beneficial and growth promoting, as is the case with many insects, plants and marine animals that use streptomycete-produced antibiotics to protect themselves against infection. This is an exciting and newly emerging field of research that will become increasingly important as the search for new antibiotics switches to unusual and under-explored environments.     

链霉菌无痕敲除方法研究进展

链霉菌是革兰氏阳性放线菌,能产生大量具有重要价值的天然代谢产物.随着基因测序技术、分子生物学和合成生物学的不断发展,人类对链霉菌家族有了更深的了解,从分子水平对其基因组进行改造的手段也越来越多.通过对链霉菌基因组合理、高效的精简,将提高链霉菌代谢产物的产量和质量,降低底物原料的消耗量.无痕敲除就是开展此项研究工作的重要手段.文章综述了近年来在链霉菌中广泛使用的分子操作方法并重点对链霉菌无痕敲除方法进行了总结.     

链霉菌基因组及次生代谢研究进展

链霉菌属革兰氏阳性放线菌,具有复杂的生活周期和次生代谢途径,并产生大量具有重要价值的天然代谢物。本文概述了链霉菌基因组染色体的独特结构与次生代谢途径的研究进展,重点论述了利用基因组信息改造和调控链霉菌次生代谢途径的研究成果。后基因组时代的功能基因组研究使人类能深入了解链霉菌家族,对链霉菌进行更加合理高效的遗传操作,为提高具有重要价值的天然代谢物的产量和获得新代谢物创造更有利的条件。     

Genome sequences of three tunicamycin-producing Streptomyces Strains, S. chartreusis NRRL 12338, S. chartreusis NRRL 3882, and S. lysosuperificus ATCC 31396

We announce the sequencing of Streptomyces chartreusis NRRL 12338 and NRRL 3882 and Streptomyces lysosuperificus ATCC 31396. These are producers of tunicamycins, chartreusins, cephalosporins, holomycins, and calcimycin. The announced genomes, together with the published Streptomyces clavuligerus genome, will facilitate data mining of these secondary metabolites.